Suchergebnisse - "Perrone, Francesco"

PubPharm (22)

1

cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors : Time for clinical implementation?

enthalten in: EBioMedicine | 2020

von Normanno, N. | De Luca, A. | Perrone, F.

CommentOn: EBioMedicine. 2020 Jul;57:102861. - PMID 32629391

2

Denosumab in early breast cancer : negative data and a call to action

enthalten in: The Lancet. Oncology | 2020

von Perrone, F. | Gravina, A.

CommentOn: Lancet Oncol. 2020 Jan;21(1):60-72. - PMID 31806543

3

Assessing Financial Toxicity in Patients With Cancer : Moving Away From a One-Size-Fits-All Approach

enthalten in: Journal of oncology practice | 2019

von Perrone, F. | Di Maio, M. | Efficace, F. | +4

CommentOn: J Oncol Pract. 2019 Apr;15(4):e300-e307. - PMID 30844331

4

Subgroup Analysis : Refining a Positive Result or Trying to Rescue a Negative One?

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Di Maio, M. | Perrone, F.

CommentOn: J Clin Oncol. 2015 May 20;33(15):1697-702. - PMID 25897150

5

Reply to P. Baldo et al

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Perrone, F. | Di Maio, M. | Gallo, C.

CommentOn: J Clin Oncol. 2015 Mar 10;33(8):910-5. - PMID 25624439

6

Adjuvant ovarian suppression in premenopausal breast cancer

enthalten in: The New England journal of medicine | 2015

von Montemurro, F. | Perrone, F. | Geuna, E.

CommentOn: N Engl J Med. 2015 Jan 29;372(5):436-46. - PMID 25495490

7

Carboplatin plus paclitaxel scheduling for advanced ovarian cancer - authors' reply

enthalten in: The Lancet. Oncology | 2014

von Pignata, S. | Di Maio, M. | Gallo, C. | +1

CommentOn: Lancet Oncol. 2014 Jun;15(7):e249-50. - PMID 24872105

8

Surrogate endpoints : can size of effect mitigate perplexity?

enthalten in: The Lancet. Oncology | 2013

von Perrone, F.

CommentOn: Lancet Oncol. 2013 Jun;14(7):619-26. - PMID 23680111

9

Reply to V. Lorusso et al

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2013

von Gridelli, C. | Gallo, C. | Butts, C. | +3

CommentOn: J Clin Oncol. 2012 Aug 20;30(24):3002-11. - PMID 22778317

10

Tackling off-label use of anticancer drugs

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Perrone, F. | de Braud, F. | Labianca, R. | +2

CommentOn: J Clin Oncol. 2012 Feb 20;30(6):661-6. - PMID 22253467